aTyr Pharma to Host Inaugural Summit Meeting on Neuropilin-2 (NRP-2) Biology

NEXT STORY
Results of Single Center Prospective Study on Delcath’s PHP Therapy Presented at ECIO 2019
PREV STORY
CureVac Granted Patent Claiming the Combination of mRNA Vaccines with Anti-PD-L1 Antibodies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

author_avatar
NASDAQ Market News

TELUS launches newest Health for Good mobile clinic to support Toronto’s most marginalized citizens

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Receives FDA Orphan Drug Designation for Treatment of Burkitt Lymphoma, and Initiates a Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia

Newark, NJ, June 28, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in ...

author_avatar
NASDAQ Market News